# SUN PHARMACEUTICAL INDUSTRIES LTD vs SATEJ M KATEKAR PROP OF ABSUN PHARMA

Court: Bombay High Court
Date: 2026-04-22
Citation: COMIP/111/2013
Petitioner: SUN PHARMACEUTICAL INDUSTRIES LTD
Respondent: SATEJ M KATEKAR PROP OF ABSUN PHARMA

[Official PDF on Bombay High Court website](https://bombayhighcourt.gov.in/bhc/file/download/eyJpdiI6InJmS2MxTVJMQUZ1cnBDd1JIUUZCYUE9PSIsInZhbHVlIjoiY2tiNng5YnNnd0U1ckRGZWhJTG4xYURvcm93SmZ4ZllBR2VJVTFTcHBaaWRURnQvbGM5ZWovenNGUjVCQzkxVnlRZXpFekZJcFRkcmY5WFV4NEt2WVE9PSIsIm1hYyI6ImMzZTJhNjA4Y2YxNjQ0YWQ3YTA2ODE0NjExODEzN2JjYjY2OTVkNTU0ZmI1NWVjMmMzMTlkYjkzZDM4MjgyZjYiLCJ0YWciOiIifQ==?expires=1782758948&signature=405d95cf8900fbb7c385a088c7433f4a0f67c2757614bc35d7f2244fd80ae5fd)

## Judgment text (excerpt)

bipin prithiani 1 comip-111.13.doc IN THE HIGH COURT OF JUDICATURE AT BOMBAY ORDINARY ORIGINAL CIVIL JURISDICTION IN ITS COMMERCIAL DIVISION COMMERCIAL IP SUIT NO. 111 OF 2013 WITH NOTICE OF MOTION NO. 27 OF 2013 IN COMMERCIAL IP SUIT NO. 111 OF 2013 Sun Pharmaceutical Industries Ltd. … Plaintiff Versus Satej M. Katekar, Proprietor of Absun Pharma … Defendant ****** Mr. Hiren Kamod a/w Mr. Nishad Nadkarni, Mr. Aasif Navodia, Ms. Khushboo Jhunjhunwala, Ms. Jaanvi Chopra and Ms. Rakshita Singh i/by Khaitan and Co. for the Plaintiff/Applicant. Mr. Rashmin Khandekar a/w Mr. Anand Mohan and Mr. Lalit Nair for Defendant. ****** CORAM : MANISH PITALE, J. RESERVED ON : 3rd FEBRUARY 2026 PRONOUNCED ON : 22nd APRIL 2026 JUDGMENT : . The plaintiff-Sun Pharmaceutical Industries Ltd. has filed this suit, seeking a decree of permanent injunction to restrain the defendant from using the impugned trade mark/trade name ‘ABSUN’/ ‘ABSUN PHARMA’ on the ground that it infringes upon the registered trade mark/house mark of the plaintiff ‘SUN’/ ‘SUN PHARMA’. The plaintiff has also sought a decree of permanent injunction restraining the defendant from using the impugned mark ‘ABSUN’/ ‘ABSUN PHARMA’, so as

https://niyam.ai/judgements/high-court/2026/april/sun-pharmaceutical-industries-ltd-vs-satej-m-katekar-prop-of-absun-pharma